| LP416103-2 | little cE Ag | COMPONENT | 1 |
| LP416104-0 | 2-Octenoate/Creatinine | COMPONENT | 1 |
| LP416105-7 | Adenovirus A+B+C+D+E DNA | COMPONENT | 1 |
| LP416106-5 | Allium schoenoprasum Ab.IgE | COMPONENT | 1 |
| LP416107-3 | Atypical porcine pestivirus RNA | COMPONENT | 2 |
| LP416108-1 | Babesia duncani Ab.IgG | COMPONENT | 1 |
| LP416109-9 | Borrelia miyamotoi Ab.IgG | COMPONENT | 1 |
| LP416110-7 | Borrelia miyamotoi Ab.IgG+IgM | COMPONENT | 1 |
| LP416111-5 | Borrelia miyamotoi Ab.IgM | COMPONENT | 1 |
| LP416112-3 | Brassica oleracea var gongylodes Ab.IgE | COMPONENT | 1 |
| LP416113-1 | Chenodeoxycholate+Cholate/Bile acid.total | COMPONENT | 2 |
| LP416114-9 | Collagen type VII IgG | COMPONENT | 2 |
| LP416115-6 | Epstein Barr virus early diffuse Ab.IgA | COMPONENT | 1 |
| LP416116-4 | Gadolinium/Creatinine | COMPONENT | 1 |
| LP416117-2 | Hantavirus seoul Ab.IgM | COMPONENT | 2 |
| LP416118-0 | Heptacarboxylporphyrin I/Creatinine | COMPONENT | 1 |
| LP416119-8 | Hexacarboxylporphyrin I/Creatinine | COMPONENT | 1 |
| LP416120-6 | Melissa officinalis Ab.IgE | COMPONENT | 1 |
| LP416122-2 | Mycoplasma hyorhinis Ab.IgG/Positive control | COMPONENT | 1 |
| LP416123-0 | N-acetylgalactosamine-4-sulfatase/N-acetylgalactosamine-6-sulfatase | COMPONENT | 1 |
| LP416124-8 | N-methyl-D-aspartate receptor subunit 1 Ab.IgG | COMPONENT | 2 |
| LP416125-5 | N-Nervonoylsphingosine/N-Lignoceroylsphingosine | COMPONENT | 1 |
| LP416126-3 | N-Palmitoylsphingosine/N-Lignoceroylsphingosine | COMPONENT | 1 |
| LP416127-1 | N-Stearoylsphingosine/N-Lignoceroylsphingosine | COMPONENT | 1 |
| LP416128-9 | Pentacarboxylporphyrin I/Creatinine | COMPONENT | 1 |
| LP416131-3 | Plasma cells.polyclonal/Cells counted | COMPONENT | 1 |
| LP416132-1 | Porcine astrovirus type 3 RNA | COMPONENT | 1 |
| LP416133-9 | RRM2B gene full mutation analysis | COMPONENT | 1 |
| LP416134-7 | Salmonella choleraesuis+infantis+typhimurium Ab/Positive control | COMPONENT | 1 |
| LP416136-2 | TYMP gene full mutation analysis | COMPONENT | 1 |
| LP416137-0 | Portable medical order form | Document.Kind | 1 |
| LP416138-8 | Medical history screening form | Document.Kind | 2 |
| LP416139-6 | Research study consent | Document.Kind | 1 |
| LP416424-2 | Anion Gap 3^1H post dose vasopressin | COMPONENT | 1 |
| LP416425-9 | Anion Gap 3^2H post dose vasopressin | COMPONENT | 1 |
| LP416426-7 | Bicarbonate^1H post dose vasopressin | COMPONENT | 1 |
| LP416427-5 | Bicarbonate^2H post dose vasopressin | COMPONENT | 1 |
| LP416428-3 | Calories burned^during activity | COMPONENT | 1 |
| LP416429-1 | Calories burned^during aerobic activity | COMPONENT | 1 |
| LP416430-9 | Calories burned^during cycling | COMPONENT | 1 |
| LP416431-7 | Calories burned^during running | COMPONENT | 1 |
| LP416432-5 | Calories burned^during swimming | COMPONENT | 1 |
| LP416433-3 | Calories burned^during walking | COMPONENT | 1 |
| LP416434-1 | Calories burned^during weight training | COMPONENT | 1 |
| LP416435-8 | Calories burned^while playing a sport | COMPONENT | 1 |
| LP416436-6 | Chloride^1H post dose vasopressin | COMPONENT | 1 |
| LP416437-4 | Chloride^2H post dose vasopressin | COMPONENT | 1 |
| LP416448-1 | Cortisol^10M post 1 ug/kg CRH IV | COMPONENT | 1 |
| LP416449-9 | Cortisol^1M pre 1 ug/kg CRH IV | COMPONENT | 1 |
| LP416450-7 | Cortisol^2M post 1 ug/kg CRH IV | COMPONENT | 1 |